NCT00274768View on ClinicalTrials.gov

Capecitabine in Treating Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

November 30, 2012

Conditions
Breast Cancer
Interventions
DRUG

capecitabine

A total of 115 cycles of therapy were administered and five patients did not complete cycle 1. The median number of cycles initiated was four (range 1-16).

Trial Locations (3)

21401

DeCesaris Cancer Institute at Anne Arundel Medical Center, Annapolis

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00274768 - Capecitabine in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter